TY - JOUR
T1 - Botulinum toxin in motor disorders
AU - Bentivoglio, Anna Rita
AU - Albanese, Alberto
PY - 1999
Y1 - 1999
N2 - Advances in the clinical use of botulinum neurotoxins continue. Of interest to the neurologist is the advanced practice in the treatment of focal dystonia and the new developments on other dyskinesias and on autonomic control of smooth muscle motility. New toxin serotypes are now being tested; their availability will improve clinical practice and will possibly lead to combined treatments. Indications in spasticity and in juvenile cerebral palsy are now under scrutiny. The combination of focal chemodenervation with specific rehabilitation procedures enables new development in this field.
AB - Advances in the clinical use of botulinum neurotoxins continue. Of interest to the neurologist is the advanced practice in the treatment of focal dystonia and the new developments on other dyskinesias and on autonomic control of smooth muscle motility. New toxin serotypes are now being tested; their availability will improve clinical practice and will possibly lead to combined treatments. Indications in spasticity and in juvenile cerebral palsy are now under scrutiny. The combination of focal chemodenervation with specific rehabilitation procedures enables new development in this field.
UR - http://www.scopus.com/inward/record.url?scp=0033396650&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033396650&partnerID=8YFLogxK
U2 - 10.1097/00019052-199908000-00012
DO - 10.1097/00019052-199908000-00012
M3 - Article
C2 - 10555834
AN - SCOPUS:0033396650
SN - 1350-7540
VL - 12
SP - 447
EP - 456
JO - Current Opinion in Neurology
JF - Current Opinion in Neurology
IS - 4
ER -